The big headlines on this release are efficiency, with OpenAI reporting that GPT-5.4 uses far fewer tokens (47% fewer on some tasks) than its predecessors).
As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results